Paths to understanding the genetic basis of autoimmune disease

Nature

Volumn 435, Issue 7042, 2005, Pages 584-589

  Rioux, John D ^a,b   Abbas, Abul K ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MONTREAL HEART INSTITUTE   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; IMMUNOLOGY; NATURAL SCIENCES; TISSUE;

AUTOIMMUNE DISEASES; GENETIC SEQUENCES; IMMUNE RESPONSES; TISSUE COMPONENTS;

GENES;

AUTOIMMUNE REGULATOR PROTEIN; CD4 ANTIGEN; COMPLEMENT COMPONENT C4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

MEDICINE;

AUTOIMMUNE DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CLONAL ANERGY; CROHN DISEASE; ENDOCRINE DISEASE; GENE MAPPING; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GRAVES DISEASE; HUMAN; IMMUNOGENETICS; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; KNOCKOUT MOUSE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; PATHOLOGY; T LYMPHOCYTE;

AUTOIMMUNE DISEASES; CLONAL ANERGY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNE TOLERANCE; T-LYMPHOCYTES;

EID: 20444438369     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature03723     Document Type: Review

References (69)

1. Walker, L. S. & Abbas, A. K. The enemy within: keeping self-reactive T cells at bay in the periphery. Nature Rev. Immunol. 2, 11-19 (2002).
2. Bjorses, P., Aaltonen, J., Horelli-Kuitunen, N., Yaspo, M. L. & Peltonen, L. Gene defect behind APECED: a new clue to autoimmunity. Hum. Mol. Genet. 7, 1547-1553 (1998).
3. Anderson, M. S. et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 298, 1395-1401 (2002).
4. Liston, A., Lesage, S., Wilson, J., Peltonen, L. & Goodnow, C. C. Aire regulates negative selection of organ-specific T cells. Nature Immunol. 4, 350-354 (2003).
5. Eisenbarth, G. S. Insulin autoimmunity: immunogenetics/immunopathogenesis of type 1A diabetes. Ann. NY Acad. Sci. 1005, 109-118 (2003).
6. Mathis, D. & Benoist, C. Back to central tolerance. Immunity 20, 509-516 (2004).
7. Salomon, B. & Bluestone, J. A. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 19, 225-252 (2001).
8. Baroja, M. L. et al. Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2A. J. Immunol. 168, 5070-5078 (2002).
9. Ueda, H. et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423, 506-511 (2003).
10. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531-562 (2004).
11. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003).
12. + regulatory T cells. Nature Immunol. 4, 330-336 (2003).
13. + T regulatory cells. Nature Immunol. 4, 337-342 (2003).
14. Nagata, S. & Suda, T. Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16, 39-43 (1995).
15. Lenardo, M. et al. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17, 221-253 (1999).
16. Fischer, A., Rieux-Laucat, F. & Le Deist, F. Autoimmune lymphoproliferative syndromes (ALPS): models for the study of peripheral tolerance. Rev. Immunogenet. 2, 52-60 (2000).
17. Sachidanandam, R. et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409, 928-933 (2001).
18. Wang, D. G. et al. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 280, 1077-1082 (1998).
19. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 431, 931-945 (2004).
20. Patil, N. et al. Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science 294, 1719-1723 (2001).
21. Daly, M. J., Rioux, J. D., Schaffner, S. F., Hudson, T. J.& Lander, E. S. High-resolution haplotype structure in the human genome. Nature Genet. 29, 229-232 (2001).
22. Jeffreys, A. J., Kauppi, L. & Neumann, R. Intensely punctate meiotic recombination in the class II region of the major histocompatibility complex. Nature Genet. 29, 217-222 (2001).
23. Gabriel, S. B. et al. The structure of haplotype blocks in the human genome. Science 296, 2225-2229 (2002).
24. Reich, D. E. et al. Human genome sequence variation and the influence of gene history, mutation and recombination. Nature Genet. 32, 135-142 (2002).
25. McVean, G. A. et al. The fine-scale structure of recombination rate variation in the human genome. Science 304, 581-584 (2004).
26. The International HapMap Consortium. The International HapMap Project. Nature 426, 789-796 (2003).
27. Hirschhorn, J. N. & Daly, M. J. Genome-wide association studies for common diseases and complex traits. Nature Rev. Genet. 6, 95-108 (2005).
28. Wang, W. Y., Barratt, B. J., Clayton, D. G. & Todd, J. A. Genome-wide association studies: theoretical and practical concerns. Nature Rev. Genet. 6, 109-118 (2005).
29. Herr, M. et al. Evaluation of fine mapping strategies for a multifactorial disease locus: systematic linkage and association analysis of IDDM1 in the HLA region on chromosome 6p21. Hum. Mol. Genet. 9, 1291-1301 (2000).
30. Hugot, J. P. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603 (2001).
31. Rioux, J. D. et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nature Genet. 29, 223-228 (2001).
32. Peltekova, V. D. et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nature Genet. 36, 471-475 (2004).
33. Laitinen, T. et al. Characterization of a common susceptibility locus for asthma-related traits. Science 304, 300-304 (2004).
34. Ogura, Y. et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606 (2001).
35. Hampe, J. et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357, 1925-1928 (2001).
36. Onengut-Gumuscu, S., Ewens, K. G., Spielman, R. S. & Concannon, P. A functional polymorphism (1858C/T) in the PTPN22 gene is linked and associated with type 1 diabetes in multiplex families. Genes Immun. 5, 678-680 (2004).
37. Smyth, D. et al. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53, 3020-3023 (2004).
38. Kyogoku, C. et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am. J. Hum. Genet. 75, 504-507 (2004).
39. Begovich, A. B. et al. Amissense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75, 330-337 (2004).
40. Lin, S. C. et al. Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus. Arthritis Rheum. 50, 770-775 (2004).
41. Prokunina, L. et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nature Genet. 32, 666-669 (2002).
42. Vijayakrishnan, L. et al. An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells. Immunity 20, 563-575 (2004).
43. Bottini, N. et al. A functional variant of lymphoid tyrosine phosphatase is associated with type 1 diabetes. Nature Genet. 36, 337-338 (2004).
44. Nishimura, H. & Honjo, T. PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol. 22, 265-268 (2001).
45. Blank, C. et al. Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4/CD8 double-negative TCR-transgenic T cells. J. Immunol. 171, 4574-4581 (2003).
46. Watanabe, T., Kitani, A., Murray, P. J. & Strober, W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nature Immunol. 5, 800-808 (2004).
47. Girardin, S. E. et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278, 8869-8872 (2003).
48. Pauleau, A. L. & Murray, P. J. Role of Nod2 in the response of macrophages to Toll-like receptor agonists. Mol. Cell. Biol. 23, 7531-7539 (2003).
49. Kobayashi, K. S. et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307, 731-734 (2005).
50. Maeda, S. et al. Nod2 mutation in Crohn's disease potentiates NF-κB activity and IL-1β processing. Science 307, 734-738 (2005).
51. Ioannidis, J. P., Ntzani, E. E., Trikalinos, T. A. & Contopoulos-Ioannidis, D. G. Replication validity of genetic association studies. Nature Genet 29, 306-309 (2001).
52. Bazerman, M. & Samuelson, W. The Winners Curse - an Empirical Investigation. Lecture Notes in Economics and Mathematical Systems 213, 186-200 (1983).
53. Lohmueller, K. E., Pearce, C. L., Pike, M., Lander, E. S. & Hirschhorn, J. N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nature Genet. 33, 177-182 (2003).
54. Hirschhorn, J. N., Lohmueller, K., Byrne, E. & Hirschhorn, K. A comprehensive review of genetic association studies. Genet. Med. 4, 45-61 (2002).
55. Ioannidis, J. P., Trikalinos, T. A., Ntzani, E. E. & Contopoulos-Ioannidis, D. G. Genetic associations in large versus small studies: an empirical assessment. Lancet 361, 567-571 (2003).
56. Daly, M. J. & Rioux, J. D. New approaches to gene hunting in IBD. Inflamm. Bowel Dis. 10, 312-317 (2004).
57. Hugot, J. P. Genetic origin of IBD. Inflamm. Bowel Dis. 10, (Suppl. 1) 511-515 (2004).
58. Alper, C. A., Awdeh, Z. & Yunis, E. J. Conserved, extended MHC haplotypes. Exp. Clin. Immunogenet. 9, 58-71 (1992).
59. Horton, R. et al. Gene map of the extended human MHC. Nature Rev. Genet. 5, 889-899 (2004).
60. Stenzel, A. et al. Patterns of linkage disequilibrium in the MHC region on human chromosome 6p. Hum. Genet. 114, 377-385 (2004).
61. Walsh, E. C. et al. An integrated haplotype map of the human major histocompatibility complex. Am. J. Hum. Genet 73, 580-590 (2003).
62. Ahmad, T. et al. Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC. Hum. Mol. Genet. 12, 647-656 (2003).
63. Miretti, M. M. et al. A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. Am. J. Hum. Genet. 76, 634-646 (2005).
64. Ahmadi, K. R. et al. A single-nucleotide polymorphism tagging set for human drug metabolism and transport. Nature Genet. 37, 84-89 (2005).
65. Tivol, E. A. et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541-547 (1995).
66. Waterhouse, P. et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270, 985-988 (1995).
67. Bennett, C. L. et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nature Genet. 27, 20-21 (2001).
68. Fisher, G. H. et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliterative syndrome. Cell 81, 935-946 (1995).
69. Atkinson, J. P. Complement deficiency: predisposing factor to autoimmune syndromes. Clin. Exp. Rheumatol. 7, (Suppl. 3) S95-S101 (1989).